Mumbai based Epigeneres Biotech has codeveloped with Tzar Labs the world's first imminent cancer detection blood test with very high specificity, that can identify cancer cells even before a tumor forms. The test requires only 10ml of blood and can identify nearly 25 different types of cancers before they are detected. Cofounder Ashish Tripathi talks to senior editor of science Sandhya Ramesh about their work, research, and future prospects of cancer detection.
​

Exclusive content, special privileges & more – Subscribe to ThePrint for Member benefits: https://theprint.in/subscribe/'>https://theprint.in/subscribe/

Connect with ThePrint
» Subscribe to ThePrint: https://theprint.in/subscribe/'>https://theprint.in/subscribe/
» Subscribe to our YouTube Channel: https://bit.ly/3nCMpht
» Like us on Facebook:   / theprintindia  
» Tweet us on Twitter:   / theprintindia  
» Follow us on Instagram:   / theprintindia  
» Find us on LinkedIn :   / theprint  
» Subscribe to ThePrint on Telegram: https://t.me/ThePrintIndia
» Find us on Spotify: https://spoti.fi/2NMVlnB
» Find us on Apple Podcasts: https://apple.co/3pEOta8